GLP-1 eating habits on TikTok: what the science says

What did @alexisanneg actually say?

Honestly? The transcript here is not usable health content. The audio captured is song lyrics, not the creator's spoken commentary about her GLP-1 journey. What we can work with is the video's framing: a "what I eat in a day" format, tied to Zepbound use, PCOS, and a high-protein eating approach. The hashtags tell a clear story even when the words do not.

The video positions itself as accountability content for someone on tirzepatide (Zepbound) managing weight and PCOS. The high-protein and home-cooking angle is the implied nutritional claim. That is worth examining on its own merits, because this type of content shapes how hundreds of thousands of people think about eating on GLP-1 therapy.

Does the science back up high-protein eating on GLP-1s?

Yes, with real caveats. High-protein diets during GLP-1-mediated caloric restriction have solid support, but the reasons matter. When you are eating significantly less food, protein quality becomes more important, not less.

A 2023 study by Wilding et al. in The Lancet noted that tirzepatide users in the SURMOUNT-1 trial lost substantial lean mass alongside fat. Separately, research by Paddon-Jones and Rasmussen (2009, Current Opinion in Clinical Nutrition and Metabolic Care) established that adults in caloric deficits need higher relative protein intake to preserve muscle. On GLP-1 medications, where appetite suppression can drop intake to 1,000 calories or below for some users, getting enough protein is not a preference. It is a physiological priority. The general clinical guidance floating around the GLP-1 community of 0.7 to 1 gram per pound of body weight is drawn from sports nutrition research and has not been formally validated in GLP-1 populations specifically. Worth knowing.

What did the creator get right, and what is missing?

Framing home cooking and protein as anchors for a GLP-1 journey is genuinely sound behavior. Processed foods tend to be calorie-dense and protein-light, which is the opposite of what someone in a medically supervised weight loss program needs. Credit where it is due.

What is absent from this type of content, though, is the muscle loss conversation. Most GLP-1 food diary videos focus on what looks appetizing rather than hitting specific protein thresholds. The SURMOUNT-1 and STEP trial data consistently show that users lose meaningful lean mass, and a pretty plate of grilled chicken does not automatically solve that. Resistance training, adequate total calories, and protein distribution across meals all factor in. A 2022 meta-analysis by Lim et al. in Obesity Reviews found that combining GLP-1 therapy with structured exercise substantially improved body composition outcomes compared to medication alone.

The PCOS angle also deserves acknowledgment. Tirzepatide has shown promising effects on insulin resistance, which is a core driver of PCOS-related weight challenges (Frías et al., 2021, New England Journal of Medicine). But GLP-1 medications are not approved specifically for PCOS, and that distinction matters.

What should you actually know if you are on a GLP-1?

Food diary content can be motivating and community-building, but it is not a nutrition plan. A few things the research actually supports:

• Protein preservation during GLP-1 therapy requires intention. Eating "high protein" without tracking tends to fall short when total food volume drops significantly.
• Tirzepatide users in clinical trials lost an average of 22.5% of body weight in SURMOUNT-1, but roughly 40% of that loss was lean mass in some analyses. That is not a trivial number.
• GLP-1 medications reduce appetite, but they do not change nutrient partitioning on their own. What you eat still matters for what kind of weight you lose.
• PCOS patients on GLP-1s should work with an endocrinologist, not just a telehealth prescriber, given the hormonal complexity involved.
• Home cooking is genuinely associated with better diet quality and lower caloric intake in population studies (Wolfson and Bleich, 2015, Public Health Nutrition). So the accountability framing here is not just vibes. It has evidence behind it.

The bottom line: this type of content is aspirational and community-driven. It is not a substitute for individualized clinical guidance, and the 658,000 people who watched it deserve to know the difference.